论文部分内容阅读
目的:分析多种利尿剂联合治疗难治性肝硬化腹水患者的临床效果。方法:将我院于2012年3月-2014年4月所接收难治性肝硬化腹水患者80例作为调查对象,分组处理后借助不同疗法治疗,即:实验组患者行多种利尿剂联合治疗,对照组患者行临床基础性治疗,判定其临床结果。结果:实验组患者临床疾病好转率(95.0%)和对照组(75.0%)相比,差异性鲜明(P<0.05)。结论:临床行多种利尿剂联合疗法治疗难治性肝硬化腹水患者作用突出,可提高疾病治愈率,值得应用。
OBJECTIVE: To analyze the clinical effect of multiple diuretics in the treatment of patients with refractory cirrhosis and ascites. Methods: Eighty patients with refractory cirrhosis and ascites who received refractory cirrhosis in our hospital from March 2012 to April 2014 were enrolled in this study. Patients were divided into groups and treated with different therapies, ie, patients in the experimental group underwent multiple diuretic combination therapy Patients in the control group underwent clinical basic treatment to determine their clinical outcome. Results: The rate of clinical disease improvement (95.0%) in the experimental group was significantly different from that in the control group (75.0%) (P <0.05). Conclusion: The combination of multiple diuretics clinical treatment of patients with refractory cirrhosis of the ascites prominent role, can improve the cure rate of the disease, it is worth applying.